The open reading frame 3 of equine arteritis virus encodes an immunogenic glycosylated, integral membrane protein - PubMed (original) (raw)
. 1999 Nov 10;264(1):92-8.
doi: 10.1006/viro.1999.9982.
Affiliations
- PMID: 10544133
- DOI: 10.1006/viro.1999.9982
Free article
The open reading frame 3 of equine arteritis virus encodes an immunogenic glycosylated, integral membrane protein
J F Hedges et al. Virology. 1999.
Free article
Abstract
Open reading frame 3 (ORF 3) of equine arteritis virus (EAV) is predicted to encode a glycosylated membrane protein (GP3) that is uncharacterized. ORF 3 of the American Type Culture Collection strain of EAV was in vitro transcribed and the encoded GP3 protein was in vitro translated with and without canine microsomal membranes. The GP3 protein was approximately 17 kDa after in vitro translation without canine microsomal membranes whereas the glycosylated form, after translation with microsomal membranes, was a diffuse band of 36-42 kDa, indicating that the GP3 protein is extensively glycosylated. Deglycosylation reduced the GP3 protein to approximately 17 kDa, the same size as that translated without microsomal membranes, indicating that the signal sequence was not cleaved. The EAV GP3 protein was membrane associated and not released as a soluble protein, in marked contrast to the ORF 3-encoded proteins of some other arteriviruses. The GP3 protein was protected from protease digestion in closed membrane vesicles, suggesting that the protein extends into the membrane vesicles and is anchored by the N-terminal signal sequence, a C-terminal hydrophobic domain, or both, but does not span the membrane three times. A GP3 protein lacking the C-terminal transmembrane domain remained membrane associated, indicating that this terminus is not a necessary membrane anchor. Sera from stallions persistently infected with EAV and horses immunized repeatedly with the modified live EAV vaccine contained antibodies specific for the GP3 protein. The data indicate that the GP3 protein is an extensively glycosylated membrane protein that is immunogenic during some EAV infections.
Copyright 1999 Academic Press.
Similar articles
- Passive transfer, rate of decay, and protein specificity of antibodies against equine arteritis virus in horses from a Standardbred herd with high seroprevalence.
Hullinger PJ, Wilson WD, Rossitto PV, Patton JF, Thurmond MC, MacLachlan NJ. Hullinger PJ, et al. J Am Vet Med Assoc. 1998 Sep 15;213(6):839-42. J Am Vet Med Assoc. 1998. PMID: 9743724 - Identification of an additional neutralization determinant of equine arteritis virus.
Zhang J, Timoney PJ, Maclachlan NJ, Balasuriya UB. Zhang J, et al. Virus Res. 2008 Dec;138(1-2):150-3. doi: 10.1016/j.virusres.2008.09.003. Epub 2008 Oct 25. Virus Res. 2008. PMID: 18851997 - ORF 3 of lactate dehydrogenase-elevating virus encodes a soluble, nonstructural, highly glycosylated, and antigenic protein.
Faaberg KS, Plagemann PG. Faaberg KS, et al. Virology. 1997 Jan 6;227(1):245-51. doi: 10.1006/viro.1996.8310. Virology. 1997. PMID: 9007081 - The immune response to equine arteritis virus: potential lessons for other arteriviruses.
Balasuriya UB, MacLachlan NJ. Balasuriya UB, et al. Vet Immunol Immunopathol. 2004 Dec 8;102(3):107-29. doi: 10.1016/j.vetimm.2004.09.003. Vet Immunol Immunopathol. 2004. PMID: 15507299 Review. - Experiences with new generation vaccines against equine viral arteritis, West Nile disease and African horse sickness.
MacLachlan NJ, Balasuriya UB, Davis NL, Collier M, Johnston RE, Ferraro GL, Guthrie AJ. MacLachlan NJ, et al. Vaccine. 2007 Jul 26;25(30):5577-82. doi: 10.1016/j.vaccine.2006.12.058. Epub 2007 Jan 16. Vaccine. 2007. PMID: 17267078 Review.
Cited by
- Importance of M-protein C terminus as substrate antigen for serodetection of equine arteritis virus infection.
Jeronimo C, Archambault D. Jeronimo C, et al. Clin Diagn Lab Immunol. 2002 May;9(3):698-703. doi: 10.1128/cdli.9.3.698-703.2002. Clin Diagn Lab Immunol. 2002. PMID: 11986280 Free PMC article. - Co-translational processing of glycoprotein 3 from equine arteritis virus: N-glycosylation adjacent to the signal peptide prevents cleavage.
Matczuk AK, Kunec D, Veit M. Matczuk AK, et al. J Biol Chem. 2013 Dec 6;288(49):35396-405. doi: 10.1074/jbc.M113.505420. Epub 2013 Oct 18. J Biol Chem. 2013. PMID: 24142700 Free PMC article. - Characterization of two new structural glycoproteins, GP(3) and GP(4), of equine arteritis virus.
Wieringa R, de Vries AA, Raamsman MJ, Rottier PJ. Wieringa R, et al. J Virol. 2002 Nov;76(21):10829-40. doi: 10.1128/jvi.76.21.10829-10840.2002. J Virol. 2002. PMID: 12368326 Free PMC article. - Envelope protein requirements for the assembly of infectious virions of porcine reproductive and respiratory syndrome virus.
Wissink EH, Kroese MV, van Wijk HA, Rijsewijk FA, Meulenberg JJ, Rottier PJ. Wissink EH, et al. J Virol. 2005 Oct;79(19):12495-506. doi: 10.1128/JVI.79.19.12495-12506.2005. J Virol. 2005. PMID: 16160177 Free PMC article. - Complex interactions between the major and minor envelope proteins of equine arteritis virus determine its tropism for equine CD3+ T lymphocytes and CD14+ monocytes.
Go YY, Zhang J, Timoney PJ, Cook RF, Horohov DW, Balasuriya UB. Go YY, et al. J Virol. 2010 May;84(10):4898-911. doi: 10.1128/JVI.02743-09. Epub 2010 Mar 10. J Virol. 2010. PMID: 20219931 Free PMC article.